Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Foot Diseases » Foot Ulcer
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Ulcer » Leg Ulcer » Foot Ulcer
Description
Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy. MeSH
Hierarchy View
Subtype Terms (1)
Diabetic Foot
153 drugs (62 approved, 91 experimental)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (24)
All India Institute of Medical Sciences
Amrita Institute of Medical Sciences
Integra LifeSciences Corporation
Jawaharlal Nehru Medical College
Mastelli srl, via Bussana Vecchia, Sanremo, Italy
Organization Involved with Phase 3 Indications (65)
Canadian Institutes of Health Research (CIHR)
Chinese University of Hong Kong
European Egyptian Pharmaceutical Industries
Fundación Cardiovascular de Colombia
Fundación Santandereana de Diabetes y Obesidad
Instituto de Salud de Bucaramanga
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mashhad University of Medical Sciences
Medical University of South Carolina
Novalead Pharma Private Limited
Rovi Pharmaceuticals Laboratories
Organization Involved with Phase 2 Indications (66)
Organization Involved with Phase 1 Indications (20)
Organization Involved with Other Experimental Indications (21)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.